mercury has been researched along with losartan potassium in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (42.86) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Johnston, GS; Mirand, EA; Murphy, GP; Schmidt, JD; Scott, WW | 1 |
Johnston, GS; Mirand, EA; Murphy, GP; Scott, WW | 1 |
Popławski, A | 1 |
Cui, K; Feldman, L; Sytkowski, AJ | 1 |
Bunn, HF; Horiguchi, H; Hradecky, P; Kayama, F; Oguma, E; Willmore, WG | 1 |
Chen, JS; Chen, PY; Chen, WY; Chung Wu, D; Huang, CL; Huang, JW; Hung, KY; Kan, YT; Lee, SH; Leu, LJ; Yang, CS | 1 |
Bellé, LP; Bianchini, A; Brandão, R; de Freitas, ML; Leite, MR; Moresco, RN; Nogueira, CW | 1 |
7 other study(ies) available for mercury and losartan potassium
Article | Year |
---|---|
Renal tumors induced by a single dose of dimethylnitrosamine: morphologic, functional, enzymatic, and hormonal characterizations.
Topics: Adenocarcinoma; Animals; Biological Assay; Blood; Erythropoietin; In Vitro Techniques; Kidney; Kidney Neoplasms; L-Lactate Dehydrogenase; Mercury; Neoplasms, Experimental; Nitrosamines; Organ Size; Pyelonephritis; Radioisotopes; Rats; Urine | 1966 |
Presence of erythropoietin in plasma of non-anemic rats with renal adenocarcinomas.
Topics: Adenocarcinoma; Animals; Erythropoietin; Hypertension, Renal; Ischemia; Kidney Diseases; Kidney Neoplasms; Male; Mercury; Nitrosamines; Radioisotopes; Rats | 1966 |
[Studies on the effect of heparin and hydrocortisone on the activity of renal erythropoietin inhibitor in experimental kidney damage].
Topics: Animals; Erythropoietin; Glucocorticoids; Heparin; Hydrocortisone; Mercury; Rats; Serum Albumin, Bovine; Trioxsalen; Uremia | 1980 |
Isolation of differentially expressed genes by cloning transcriptionally active DNA fragments.
Topics: Animals; Blotting, Northern; Cell Nucleus; Cloning, Molecular; DNA; Erythropoietin; Gene Expression Regulation; Genetic Techniques; Leukemia, Erythroblastic, Acute; Mercury; Mice; Nucleosomes; Polymerase Chain Reaction; Sequence Analysis, DNA; Transcription, Genetic; Tumor Cells, Cultured | 1999 |
Cadmium and platinum suppression of erythropoietin production in cell culture: clinical implications.
Topics: Cadmium; Cell Survival; Cisplatin; Cobalt; DNA-Binding Proteins; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Environmental Exposure; Erythropoietin; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Mercury; Metals, Heavy; Nuclear Proteins; Protein Binding; RNA, Messenger; Transcription Factors; Tumor Cells, Cultured; Zinc | 2000 |
Trace Metals' abnormalities in hemodialysis patients: relationship with medications.
Topics: Acetates; Aluminum; Aluminum Hydroxide; Cadmium; Calcitriol; Calcium; Calcium Carbonate; Calcium Compounds; Case-Control Studies; Chelating Agents; Chi-Square Distribution; Copper; Cross-Sectional Studies; Erythropoietin; Female; Hematocrit; Humans; Hydroxycholecalciferols; Kidney Failure, Chronic; Lead; Male; Mercury; Metals; Middle Aged; Phosphates; Renal Dialysis; Spectrophotometry, Atomic; Sucralfate; Trace Elements; Zinc | 2000 |
Diphenyl diselenide potentiates nephrotoxicity induced by mercuric chloride in mice.
Topics: Acute Kidney Injury; Animals; Ascorbic Acid; Benzene Derivatives; Catalase; Creatinine; Erythropoietin; Glutathione Transferase; Kidney; Liver; Male; Mercuric Chloride; Mercury; Mice; Organoselenium Compounds; Oxidative Stress; Porphobilinogen Synthase; Thiobarbituric Acid Reactive Substances; Urea | 2011 |